Li Zhifeng相关文献与解析，生知库 | 链接生命科学的每一步

Construction of Full-Spectrum-Response Bi(3)O(4)Br:Er(3+)@Bi(2)O(3-) (x) S-Scheme Heterojunction With [Bi─O] Tetrahedral Sharing by Integrated Upconversion and Photothermal Effect Toward Optimized Photocatalytic Performance

通过整合上转换和光热效应，构建具有[Bi─O]四面体共享的全光谱响应Bi(3)O(4)Br:Er(3+)@Bi(2)O(3-) (x) S型异质结，以实现优化的光催化性能

期刊:Advanced Science

影响因子:14.1

doi:10.1002/advs.202412214

Li, Zhifeng; Xu, Liang; Yin, Zhaoyi; Ma, Junhao; Dong, Xiaoyi; Wang, Shangyong; Song, Zhiguo; Qiu, Jianbei; Li, Yongjin

发表日期：2025

文献求助收藏

Manganese-enriched nanoboron agent amplifies BNCT efficacy via pyroptosis-mediated immune activation and STING pathway synergy

富含锰的纳米硼制剂通过细胞焦亡介导的免疫激活和STING通路协同作用增强硼中子俘获疗法的疗效。

期刊:Journal of Nanobiotechnology

影响因子:12.6

doi:10.1186/s12951-025-03916-8

Zhang, Zhicheng; Sun, Xiaoyan; Qin, Yaxin; Yang, Yufan; Dai, Qi; Bao, Xiaoyan; Suzuki, Minoru; Wang, Sheng; Yang, Zai; Li, Zhifeng; Han, Min; Xu, Donghang; Wei, Qichun

A machine learning-based model to predict POD24 in follicular lymphoma: a study by the Chinese workshop on follicular lymphoma

基于机器学习的滤泡性淋巴瘤POD24预测模型：中国滤泡性淋巴瘤研讨会的一项研究

期刊:Biomarker Research

影响因子:11.5

doi:10.1186/s40364-024-00716-4

Zha, Jie; Chen, Qinwei; Zhang, Wei; Jing, Hongmei; Ye, Jingjing; Liu, Huanhuan; Yu, Haifeng; Yi, Shuhua; Li, Caixia; Zheng, Zhong; Xu, Wei; Li, Zhifeng; Lin, Zhijuan; Ping, Lingyan; He, Xiaohua; Zhang, Liling; Xie, Ying; Chen, Feili; Sun, Xiuhua; Su, Liping; Zhang, Huilai; Yang, Haiyan; Zhao, Weili; Qiu, Lugui; Li, Zhiming; Song, Yuqin; Xu, Bing

淋巴瘤

发表日期：2025

文献求助收藏

De novo discovery of a molecular glue-like macrocyclic peptide that induces MCL1 homodimerization.

从头发现一种分子胶状大环肽，可诱导 MCL1 同源二聚化

期刊:Proceedings of the National Academy of Sciences of the United States of America

影响因子:9.1

doi:10.1073/pnas.2426006122

Li Fengwei, Zhang Mengmeng, Liu Chao, Cheng Jie, Yang Yawen, Peng Xiangda, Li Zhifeng, Cai Wenfeng, Yu Haipeng, Wu Junjie, Guo Yuyu, Geng Hongkun, Fa Yun, Zhang Youming, Wu Dalei, Yin Yizhen

其它

发表日期：2025

文献求助收藏

Dynamic change in Epstein-Barr virus DNA predicts prognosis in early stage natural killer/T-cell lymphoma with pegaspargase-based treatment: long-term follow-up and biomarker analysis from the NHL-004 multicenter randomized study

Epstein-Barr病毒DNA的动态变化可预测早期自然杀伤/T细胞淋巴瘤患者接受培门冬酶治疗后的预后：来自NHL-004多中心随机研究的长期随访和生物标志物分析

期刊:Haematologica

影响因子:7.9

doi:10.3324/haematol.2025.287513

Zhong, Huijuan; Cheng, Shu; Xiong, Jie; Chen, Jiayi; Mu, Rongji; Yang, Haoxu; Yi, Hongmei; Song, Qi; Zhang, Hao; Hu, Yu; Cui, Guohui; Wei, Juying; Zhang, Xi; Xu, Bing; Qian, Wenbin; Huang, Xiaobing; Hou, Ming; Yan, Feng; Wang, Xin; Song, Yongping; Liu, Yuanhua; Ma, Xuejun; Hu, Jianda; Li, Fei; Wu, Chongyang; Chen, Junmin; Yu, Li; Bai, Ou; Xu, Jingyan; Zhu, Zunmin; Liu, Li; Zhou, Xin; Huang, Li; Tong, Yin; Niu, Ting; Wu, Depei; Jiang, Xufeng; Wang, Chaofu; Ouyang, Binshen; Cai, Gang; Li, Biao; Liu, Jia; Li, Zhifeng; Xiao, Rong; Wang, Luqun; Jiang, Yujie; Liu, Yanyan; Zheng, Xiaoyun; Xu, Pengpeng; Wang, Li; Chen, Saijuan; Zhao, Wei-Li

Interpretable machine learning algorithms reveal gut microbiome features associated with atopic dermatitis

可解释的机器学习算法揭示了与特应性皮炎相关的肠道微生物组特征

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2025.1528046

Ma, Jingtai; Fang, Yiting; Li, Shiqi; Zeng, Lilian; Chen, Siyi; Li, Zhifeng; Ji, Guiyuan; Yang, Xingfen; Wu, Wei

微生物学

发表日期：2025

文献求助收藏

Innovative microbial strategies in atopic dermatitis

特应性皮炎的创新微生物治疗策略

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2025.1605434

Ma, Jingtai; Fang, Yiting; Hu, Jinxing; Li, Shiqi; Zeng, Lilian; Chen, Siyi; Li, Zhifeng; Meng, Ruiling; Yang, Xingfen; Zhang, Fenglin; Ji, Guiyuan; Liao, Peihua; Chen, Liang; Wu, Wei

微生物学

发表日期：2025

文献求助收藏

Evolution and the potential for human-to-human transmission of severe fever with thrombocytopenia syndrome virus in low transmission settings in China

在中国低传播地区，发热伴血小板减少综合征病毒的演变及其人际传播的可能性

期刊:New Microbes and New Infections

影响因子:5.4

doi:10.1016/j.nmni.2025.101650

Wang, Yin; Huang, Yao; Liang, Jie; Li, Qiumei; Zhu, Liguo; Liang, Shuyi; Li, Zhifeng; Xu, Chaojie; Hu, Jianli; Gu, Yun; Ge, Yuyang; Zhang, Xiuling; Wei, Zhengya; Zhou, Luojing; Lu, Guangyu

Cost-effectiveness analysis of first-line versus second-line use of CDK4/6 inhibitors combined with endocrine therapy in advanced HR+/HER2- breast cancer in China: based on the SONIA trial

基于SONIA试验，对中国晚期HR+/HER2-乳腺癌一线与二线应用CDK4/6抑制剂联合内分泌治疗的成本效益进行分析

期刊:Frontiers in Pharmacology

影响因子:4.8

doi:10.3389/fphar.2025.1700291

Jin, Xiaohu; Li, Zhifeng

Propionate metabolism-related molecular subtypes and prognostic signature in lung adenocarcinoma

丙酸代谢相关分子亚型及肺腺癌预后特征

Construction of Full-Spectrum-Response Bi(3)O(4)Br:Er(3+)@Bi(2)O(3-) (x) S-Scheme Heterojunction With [Bi─O] Tetrahedral Sharing by Integrated Upconversion and Photothermal Effect Toward Optimized Photocatalytic Performance

通过整合上转换和光热效应，构建具有[Bi─O]四面体共享的全光谱响应Bi(3)O(4)Br:Er(3+)@Bi(2)O(3-) (x) S型异质结，以实现优化的光催化性能

Manganese-enriched nanoboron agent amplifies BNCT efficacy via pyroptosis-mediated immune activation and STING pathway synergy

富含锰的纳米硼制剂通过细胞焦亡介导的免疫激活和STING通路协同作用增强硼中子俘获疗法的疗效。

A machine learning-based model to predict POD24 in follicular lymphoma: a study by the Chinese workshop on follicular lymphoma

基于机器学习的滤泡性淋巴瘤POD24预测模型：中国滤泡性淋巴瘤研讨会的一项研究

De novo discovery of a molecular glue-like macrocyclic peptide that induces MCL1 homodimerization.

从头发现一种分子胶状大环肽，可诱导 MCL1 同源二聚化

Dynamic change in Epstein-Barr virus DNA predicts prognosis in early stage natural killer/T-cell lymphoma with pegaspargase-based treatment: long-term follow-up and biomarker analysis from the NHL-004 multicenter randomized study

Epstein-Barr病毒DNA的动态变化可预测早期自然杀伤/T细胞淋巴瘤患者接受培门冬酶治疗后的预后：来自NHL-004多中心随机研究的长期随访和生物标志物分析

Interpretable machine learning algorithms reveal gut microbiome features associated with atopic dermatitis

可解释的机器学习算法揭示了与特应性皮炎相关的肠道微生物组特征

Innovative microbial strategies in atopic dermatitis

特应性皮炎的创新微生物治疗策略

Evolution and the potential for human-to-human transmission of severe fever with thrombocytopenia syndrome virus in low transmission settings in China

在中国低传播地区，发热伴血小板减少综合征病毒的演变及其人际传播的可能性

Cost-effectiveness analysis of first-line versus second-line use of CDK4/6 inhibitors combined with endocrine therapy in advanced HR+/HER2- breast cancer in China: based on the SONIA trial

基于SONIA试验，对中国晚期HR+/HER2-乳腺癌一线与二线应用CDK4/6抑制剂联合内分泌治疗的成本效益进行分析

Propionate metabolism-related molecular subtypes and prognostic signature in lung adenocarcinoma

丙酸代谢相关分子亚型及肺腺癌预后特征

Construction of Full-Spectrum-Response Bi(3)O(4)Br:Er(3+)@Bi(2)O(3-) (x) S-Scheme Heterojunction With [Bi─O] Tetrahedral Sharing by Integrated Upconversion and Photothermal Effect Toward Optimized Photocatalytic Performance

通过整合上转换和光热效应，构建具有[Bi─O]四面体共享的全光谱响应Bi(3)O(4)Br:Er(3+)@Bi(2)O(3-) (x) S型异质结，以实现优化的光催化性能

Manganese-enriched nanoboron agent amplifies BNCT efficacy via pyroptosis-mediated immune activation and STING pathway synergy​

富含锰的纳米硼制剂通过细胞焦亡介导的免疫激活和STING通路协同作用增强硼中子俘获疗法的疗效。

A machine learning-based model to predict POD24 in follicular lymphoma: a study by the Chinese workshop on follicular lymphoma

基于机器学习的滤泡性淋巴瘤POD24预测模型：中国滤泡性淋巴瘤研讨会的一项研究

De novo discovery of a molecular glue-like macrocyclic peptide that induces MCL1 homodimerization.

从头发现一种分子胶状大环肽，可诱导 MCL1 同源二聚化

Dynamic change in Epstein-Barr virus DNA predicts prognosis in early stage natural killer/T-cell lymphoma with pegaspargase-based treatment: long-term follow-up and biomarker analysis from the NHL-004 multicenter randomized study

Epstein-Barr病毒DNA的动态变化可预测早期自然杀伤/T细胞淋巴瘤患者接受培门冬酶治疗后的预后：来自NHL-004多中心随机研究的长期随访和生物标志物分析

Interpretable machine learning algorithms reveal gut microbiome features associated with atopic dermatitis

可解释的机器学习算法揭示了与特应性皮炎相关的肠道微生物组特征

Innovative microbial strategies in atopic dermatitis

特应性皮炎的创新微生物治疗策略

Evolution and the potential for human-to-human transmission of severe fever with thrombocytopenia syndrome virus in low transmission settings in China

在中国低传播地区，发热伴血小板减少综合征病毒的演变及其人际传播的可能性

Cost-effectiveness analysis of first-line versus second-line use of CDK4/6 inhibitors combined with endocrine therapy in advanced HR+/HER2- breast cancer in China: based on the SONIA trial

基于SONIA试验，对中国晚期HR+/HER2-乳腺癌一线与二线应用CDK4/6抑制剂联合内分泌治疗的成本效益进行分析

Manganese-enriched nanoboron agent amplifies BNCT efficacy via pyroptosis-mediated immune activation and STING pathway synergy